Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BEIJING

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 23
  • 0 comments

FDA approve FLUVASTATIN SODIUM

Comment Full text

RECORDATI RARE

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 23
  • 0 comments

FDA approve PASIREOTIDE DIASPARTATE

Comment Full text

APOTEX

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 25
  • 0 comments

FDA approve ELIGLUSTAT TARTRATE

Comment Full text

HIKMA

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 25
  • 0 comments

FDA approve AZATHIOPRINE SODIUM

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 22
  • 0 comments

FDA approve LANREOTIDE ACETATE

Comment Full text

PADAGIS US

  • FDA Approval
  • July 12, 2024, 09:02 UTC
  • 29
  • 0 comments

FDA approve LOTEPREDNOL ETABONATE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • July 12, 2024, 09:02 UTC
  • 27
  • 0 comments

FDA approve ESMOLOL HYDROCHLORIDE

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • July 12, 2024, 09:02 UTC
  • 26
  • 0 comments

FDA approve POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Comment Full text

PFIZER

  • FDA Approval
  • July 12, 2024, 09:02 UTC
  • 21
  • 0 comments

FDA approve MEDROXYPROGESTERONE ACETATE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • July 12, 2024, 09:02 UTC
  • 24
  • 0 comments

FDA approve RISEDRONATE SODIUM

Comment Full text
  • Previous
  • 308
  • 309
  • 310
  • 311
  • 312
  • Next

Search

News categories

  • Technical Exchange News(9990)
  • Event(412)
  • SEC News(169512)
  • FDA Approval(9401)
  • Company Report(721)
  • Business News(112908)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin